Houston, Texas • Serving All 50 States Free Shipping Over $99 (+1) 281-836-5422

Continuous Glucose Monitor / Receiver, Non-Adjunctive — HCPCS E2103

Insurance Billable

Non-adjunctive, non-implanted continuous glucose monitor or receiver — treatment decisions without confirmatory fingersticks. HCPCS Code: E2103 — billable through Medicare and most insurance plans.

Continuous Glucose Monitor / Receiver, Non-Adjunctive — Fingerstick-Free Glucose Monitoring | HCPCS E2103

This non-adjunctive, non-implanted Continuous Glucose Monitor (CGM) / receiver tracks glucose levels around the clock — and because it is classified as non-adjunctive, patients and providers can make treatment decisions directly from its readings, without confirmatory fingersticks. Designed for patients managing diabetes with insulin or those with a history of problematic hypoglycemia, the system replaces routine finger pricks with continuous, real-time glucose data.

A small wearable sensor measures glucose continuously and transmits readings to the receiver or compatible display device, complete with trend arrows and customizable alerts that warn of highs and lows before they become emergencies. As durable medical equipment, it qualifies under HCPCS code E2103 — billable through Medicare and most major insurance plans with a valid physician’s order.

HSA & FSA Eligible


Key Benefits

  • No Confirmatory Fingersticks: Non-adjunctive classification means dosing decisions can be made directly from CGM readings.
  • 24/7 Glucose Visibility: Continuous readings reveal patterns that periodic fingersticks miss — overnight, after meals, during exercise.
  • Hypoglycemia Protection: Real-time alerts warn of dropping glucose before dangerous lows occur.
  • Trend-Based Dosing: Directional arrows show where glucose is heading, enabling smarter insulin decisions.
  • Insurance Covered: Billable under HCPCS E2103 through Medicare and most insurance plans.

Design Features

Non-Adjunctive Accuracy

FDA-cleared for treatment decisions without fingerstick confirmation — readings you can act on.

Continuous Sensor Readings

Glucose measured automatically throughout the day and night — no routine finger pricks.

High & Low Alerts

Customizable alarms notify patients before glucose reaches dangerous levels.

Trend Arrows

Directional indicators show whether glucose is rising, falling, or steady — and how fast.

Non-Implanted Wearable

Discreet on-body sensor applies easily at home — no surgical procedure required.

Data Sharing & Reports

Glucose history can be shared with physicians and caregivers for better-informed care.


Commonly Prescribed For

  • Diabetes management on insulin (Type 1 & Type 2)
  • History of problematic hypoglycemia
  • Hypoglycemia unawareness
  • Frequent glucose fluctuations requiring close monitoring
  • Intensive insulin therapy (multiple daily injections or pump)
  • Patients needing overnight glucose visibility

How It Works

A small sensor worn on the body measures glucose in the interstitial fluid continuously, transmitting readings to the receiver or a compatible display. Because the system is non-adjunctive, its accuracy is FDA-validated for direct treatment decisions — patients can dose insulin, treat lows, and adjust care based on CGM readings alone. Trend arrows add predictive context: a reading of 120 mg/dL falling rapidly calls for very different action than 120 mg/dL holding steady. Alerts work silently in the background, warning the patient — even from sleep — before glucose reaches dangerous territory.


Insurance & Billing

HCPCS Code: E2103 — Non-adjunctive, non-implanted continuous glucose monitor or receiver.

VELO Healthcare bills Medicare and most major insurance plans directly with a valid physician’s order.

Billing notes: The KF modifier applies only when the device is FDA Class III. Monthly CGM supplies (sensors and related items) are billed separately under HCPCS A4239.

Submit a request or call (+1) 281-836-5422 to verify your coverage — our team handles the paperwork for you.


Technical Specifications

  • Device Type: Continuous Glucose Monitor / Receiver
  • Classification: Non-Adjunctive, Non-Implanted
  • Function: Direct Treatment Decisions — No Confirmatory Fingersticks
  • Alerts: Customizable High / Low Glucose Notifications
  • HCPCS Code: E2103 (Device) / A4239 (Monthly Supplies)
  • Modifier: KF (FDA Class III devices only)
  • Billing: Medicare & Most Insurance Plans
  • Pack Size: 1 Each

Why Choose VELO?

  • Direct insurance billing — Medicare and most major plans accepted
  • Physician order coordination handled by our team
  • Monthly supply reordering managed for you (A4239)
  • Fast delivery across Houston and beyond
  • HSA & FSA eligible

Conclusion

This non-adjunctive CGM / receiver (HCPCS E2103) replaces routine fingersticks with continuous, actionable glucose data — real-time readings, trend arrows, and life-protecting alerts in one wearable system. For patients on insulin or living with problematic hypoglycemia, VELO Healthcare makes advanced glucose monitoring simple with direct Medicare and insurance billing plus managed monthly supplies.

HCPCS Code

E2103

Reviews

There are no reviews yet.

Be the first to review “Continuous Glucose Monitor / Receiver, Non-Adjunctive — HCPCS E2103”

Your email address will not be published. Required fields are marked *

Ready to get your equipment covered by insurance?

Submit your details — our team verifies your coverage and contacts you within 1 business day. No payment required.

Check Insurance Eligibility
Top